Evolent Health, Inc.EVHNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank92
3Y CAGR+15.4%
5Y CAGR+18.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+15.4%/yr
vs +33.3%/yr prior
5Y CAGR
+18.0%/yr
Consistent
Acceleration
-17.9pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.59B | -27.2% |
| 2024 | $2.19B | +45.5% |
| 2023 | $1.50B | +45.2% |
| 2022 | $1.04B | +57.5% |
| 2021 | $657.55M | -5.6% |
| 2020 | $696.58M | +35.8% |
| 2019 | $513.03M | +56.5% |
| 2018 | $327.82M | +21.7% |
| 2017 | $269.35M | +73.6% |
| 2016 | $155.18M | - |